AXGN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Axogen Inc (AXGN).


$725.26M Market Cap.

As of 02/27/2025 5:00 PM ET (MRY) • Disclaimer

AXGN Market Cap. (MRY)


AXGN Shares Outstanding (MRY)


AXGN Assets (MRY)


Total Assets

$203.73M

Total Liabilities

$99.82M

Total Investments

$5.93M

AXGN Income (MRY)


Revenue

$187.34M

Net Income

-$9.96M

Operating Expense

$145.26M

AXGN Cash Flow (MRY)


CF Operations

$4.54M

CF Investing

-$10.30M

CF Financing

$2.29M

AXGN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AXGN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$203,728,000 (3.51%)

$196,827,000 (0.74%)

$195,387,000 (-6.07%)

$208,024,000 (3.30%)

Assets Current

$99,217,000 (12.74%)

$88,004,000 (-10.27%)

$98,075,000 (-22.81%)

$127,049,000 (-12.53%)

Assets Non-Current

$104,511,000 (-3.96%)

$108,823,000 (11.83%)

$97,312,000 (20.18%)

$80,975,000 (44.26%)

Goodwill & Intangible Assets

$5,579,000 (23.13%)

$4,531,000 (24.17%)

$3,649,000 (27.63%)

$2,859,000 (39.19%)

Shareholders Equity

$103,907,000 (8.62%)

$95,665,000 (-5.28%)

$100,999,000 (-10.26%)

$112,550,000 (-8.61%)

Property Plant & Equipment Net

$98,932,000 (-5.14%)

$104,292,000 (11.35%)

$93,663,000 (19.90%)

$78,116,000 (44.46%)

Cash & Equivalents

$33,554,000 (-9.38%)

$37,026,000 (71.93%)

$21,535,000 (-44.79%)

$39,007,000 (-29.85%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$5,928,000 (0%)

$0 (0%)

$33,505,000 (-34.73%)

$51,330,000 (-7.01%)

Investments Current

$5,928,000 (0%)

$0 (0%)

$33,505,000 (-34.73%)

$51,330,000 (-7.01%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$33,183,000 (44.15%)

$23,020,000 (21.77%)

$18,905,000 (13.25%)

$16,693,000 (33.23%)

Trade & Non-Trade Receivables

$24,105,000 (-4.14%)

$25,147,000 (13.35%)

$22,186,000 (22.18%)

$18,158,000 (3.07%)

Trade & Non-Trade Payables

$28,641,000 (-0.84%)

$28,883,000 (28.69%)

$22,443,000 (-0.07%)

$22,459,000 (2.24%)

Accumulated Retained Earnings (Deficit)

-$291,260,000 (-3.54%)

-$281,296,000 (-8.37%)

-$259,580,000 (-12.55%)

-$230,632,000 (-13.25%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$71,086,000 (-1.65%)

$72,279,000 (0.46%)

$71,945,000 (-1.47%)

$73,015,000 (29.78%)

Debt Current

$1,969,000 (27.28%)

$1,547,000 (18.09%)

$1,310,000 (-28.57%)

$1,834,000 (112.51%)

Debt Non-Current

$69,117,000 (-2.28%)

$70,732,000 (0.14%)

$70,635,000 (-0.77%)

$71,181,000 (28.49%)

Total Liabilities

$99,821,000 (-1.33%)

$101,162,000 (7.18%)

$94,388,000 (-1.14%)

$95,474,000 (22.04%)

Liabilities Current

$30,610,000 (0.59%)

$30,430,000 (28.11%)

$23,753,000 (-2.22%)

$24,293,000 (6.40%)

Liabilities Non-Current

$69,211,000 (-2.15%)

$70,732,000 (0.14%)

$70,635,000 (-0.77%)

$71,181,000 (28.48%)

AXGN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$187,338,000 (17.81%)

$159,012,000 (14.74%)

$138,584,000 (8.81%)

$127,358,000 (13.41%)

Cost of Revenue

$45,361,000 (45.68%)

$31,138,000 (28.95%)

$24,147,000 (5.30%)

$22,931,000 (6.26%)

Selling General & Administrative Expense

$117,497,000 (-2.90%)

$121,003,000 (3.43%)

$116,986,000 (10.71%)

$105,666,000 (10.01%)

Research & Development Expense

$27,767,000 (-2.00%)

$28,333,000 (4.33%)

$27,158,000 (12.33%)

$24,177,000 (35.48%)

Operating Expenses

$145,264,000 (-2.73%)

$149,336,000 (3.60%)

$144,144,000 (11.01%)

$129,843,000 (14.00%)

Interest Expense

$8,206,000 (189.45%)

$2,835,000 (354.33%)

$624,000 (-53.98%)

$1,356,000 (28.65%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$9,964,000 (54.12%)

-$21,716,000 (24.98%)

-$28,948,000 (-7.27%)

-$26,985,000 (-13.45%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$9,964,000 (54.12%)

-$21,716,000 (24.98%)

-$28,948,000 (-7.27%)

-$26,985,000 (-13.45%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$9,964,000 (54.12%)

-$21,716,000 (24.98%)

-$28,948,000 (-7.27%)

-$26,985,000 (-13.45%)

Weighted Average Shares

$44,257,754 (3.22%)

$42,878,543 (1.89%)

$42,083,125 (2.11%)

$41,214,889 (3.12%)

Weighted Average Shares Diluted

$44,257,754 (3.22%)

$42,878,543 (1.89%)

$42,083,125 (2.11%)

$41,214,889 (3.12%)

Earning Before Interest & Taxes (EBIT)

-$1,758,000 (90.69%)

-$18,881,000 (33.34%)

-$28,324,000 (-10.52%)

-$25,629,000 (-12.74%)

Gross Profit

$141,977,000 (11.03%)

$127,874,000 (11.74%)

$114,437,000 (9.59%)

$104,427,000 (15.11%)

Operating Income

-$3,287,000 (84.68%)

-$21,462,000 (27.75%)

-$29,707,000 (-16.88%)

-$25,416,000 (-9.64%)

AXGN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$10,297,000 (-153.48%)

$19,253,000 (701.66%)

-$3,200,000 (86.47%)

-$23,649,000 (-39.42%)

Net Cash Flow from Financing

$2,290,000 (17.20%)

$1,954,000 (8.92%)

$1,794,000 (-91.23%)

$20,452,000 (-49.47%)

Net Cash Flow from Operations

$4,535,000 (179.34%)

-$5,716,000 (64.42%)

-$16,066,000 (-19.85%)

-$13,405,000 (-39.26%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,472,000 (-122.41%)

$15,491,000 (188.66%)

-$17,472,000 (-5.24%)

-$16,602,000 (-219.57%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$5,773,000 (-116.89%)

$34,171,000 (89.28%)

$18,053,000 (374.95%)

$3,801,000 (-32.53%)

Capital Expenditure

-$3,101,000 (77.65%)

-$13,872,000 (30.91%)

-$20,078,000 (27.81%)

-$27,811,000 (-26.96%)

Issuance (Repayment) of Debt Securities

-$10,000 (0.00%)

-$10,000 (16.67%)

-$12,000 (-100.08%)

$14,985,000 (-56.37%)

Issuance (Purchase) of Equity Shares

$2,300,000 (17.11%)

$1,964,000 (8.75%)

$1,806,000 (-66.97%)

$5,467,000 (-19.60%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$15,906,000 (10.32%)

$14,418,000 (-7.52%)

$15,591,000 (42.79%)

$10,919,000 (28.91%)

Depreciation Amortization & Accretion

$7,837,000 (41.13%)

$5,553,000 (14.42%)

$4,853,000 (2.36%)

$4,741,000 (37.02%)

AXGN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

75.80% (-5.72%)

80.40% (-2.66%)

82.60% (0.73%)

82.00% (1.49%)

Profit Margin

-5.30% (61.31%)

-13.70% (34.45%)

-20.90% (1.42%)

-21.20% (0.00%)

EBITDA Margin

3.20% (138.10%)

-8.40% (50.30%)

-16.90% (-3.05%)

-16.40% (4.65%)

Return on Average Equity (ROAE)

-10.20% (54.46%)

-22.40% (21.13%)

-28.40% (-22.41%)

-23.20% (-18.97%)

Return on Average Assets (ROAA)

-5.20% (53.57%)

-11.20% (24.32%)

-14.80% (-12.98%)

-13.10% (2.24%)

Return on Sales (ROS)

-0.90% (92.44%)

-11.90% (41.67%)

-20.40% (-1.49%)

-20.10% (0.50%)

Return on Invested Capital (ROIC)

-0.80% (91.30%)

-9.20% (28.13%)

-12.80% (0.00%)

-12.80% (25.58%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-71.65 (-435.04%)

-13.39 (7.41%)

-14.46 (-0.34%)

-14.41 (51.68%)

Price to Sales Ratio (P/S)

3.89 (111.35%)

1.84 (-39.23%)

3.03 (-0.03%)

3.03 (-52.41%)

Price to Book Ratio (P/B)

6.98 (127.14%)

3.07 (-26.45%)

4.18 (20.75%)

3.46 (-40.67%)

Debt to Equity Ratio (D/E)

0.96 (-9.08%)

1.06 (13.05%)

0.94 (10.26%)

0.85 (33.54%)

Earnings Per Share (EPS)

-0.23 (54.90%)

-0.51 (26.09%)

-0.69 (-6.15%)

-0.65 (-8.33%)

Sales Per Share (SPS)

4.23 (14.16%)

3.71 (12.60%)

3.29 (6.57%)

3.09 (9.96%)

Free Cash Flow Per Share (FCFPS)

0.03 (107.00%)

-0.46 (46.80%)

-0.86 (14.10%)

-1 (-26.74%)

Book Value Per Share (BVPS)

2.35 (5.24%)

2.23 (-7.04%)

2.4 (-12.12%)

2.73 (-11.36%)

Tangible Assets Book Value Per Share (TABVPS)

4.48 (-0.18%)

4.49 (-1.56%)

4.56 (-8.48%)

4.98 (-0.18%)

Enterprise Value Over EBIT (EV/EBIT)

-439 (-2482.35%)

-17 (0.00%)

-17 (-6.25%)

-16 (48.39%)

Enterprise Value Over EBITDA (EV/EBITDA)

126.98 (615.71%)

-24.62 (-22.05%)

-20.17 (-2.93%)

-19.6 (46.53%)

Asset Turnover

0.97 (18.10%)

0.82 (16.57%)

0.71 (14.42%)

0.62 (-2.53%)

Current Ratio

3.24 (12.07%)

2.89 (-29.96%)

4.13 (-21.05%)

5.23 (-17.79%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$1,434,000 (107.32%)

-$19,588,000 (45.81%)

-$36,144,000 (12.31%)

-$41,216,000 (-30.72%)

Enterprise Value (EV)

$771,901,108 (135.22%)

$328,161,829 (-30.70%)

$473,509,168 (15.66%)

$409,383,178 (-42.05%)

Earnings Before Tax (EBT)

-$9,964,000 (54.12%)

-$21,716,000 (24.98%)

-$28,948,000 (-7.27%)

-$26,985,000 (-13.45%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$6,079,000 (145.61%)

-$13,328,000 (43.22%)

-$23,471,000 (-12.37%)

-$20,888,000 (-8.39%)

Invested Capital

$205,071,000 (4.03%)

$197,119,000 (-9.74%)

$218,395,000 (1.64%)

$214,880,000 (21.30%)

Working Capital

$68,607,000 (19.16%)

$57,574,000 (-22.53%)

$74,322,000 (-27.67%)

$102,756,000 (-16.06%)

Tangible Asset Value

$198,149,000 (3.04%)

$192,296,000 (0.29%)

$191,738,000 (-6.54%)

$205,165,000 (2.93%)

Market Capitalization

$725,256,108 (146.70%)

$293,987,829 (-30.34%)

$422,020,168 (8.37%)

$389,441,178 (-45.78%)

Average Equity

$98,039,250 (1.03%)

$97,035,000 (-4.86%)

$101,996,250 (-12.49%)

$116,559,500 (-4.62%)

Average Assets

$192,790,250 (-0.18%)

$193,143,000 (-1.59%)

$196,254,000 (-4.95%)

$206,474,000 (16.30%)

Invested Capital Average

$207,869,250 (1.03%)

$205,741,500 (-7.16%)

$221,603,000 (10.64%)

$200,295,000 (51.81%)

Shares

44,008,259 (2.24%)

43,043,606 (1.79%)

42,286,590 (1.74%)

41,562,559 (3.58%)